574 related articles for article (PubMed ID: 27513632)
1. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
2. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
[TBL] [Abstract][Full Text] [Related]
3. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
5. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
8. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N
Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557
[TBL] [Abstract][Full Text] [Related]
10. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
[TBL] [Abstract][Full Text] [Related]
11. Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression.
Qian W; Cai X; Qian Q; Zhang W; Tian L
J Cell Mol Med; 2020 Jun; 24(11):5998-6007. PubMed ID: 32187849
[TBL] [Abstract][Full Text] [Related]
12. Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition.
Zheng Q; Tong M; Ou B; Liu C; Hu C; Yang Y
Int J Mol Med; 2019 Jan; 43(1):117-126. PubMed ID: 30387812
[TBL] [Abstract][Full Text] [Related]
13. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
[TBL] [Abstract][Full Text] [Related]
17. The Role of miR-497/EIF3A Axis in TGFβ1-Induced Epithelial-Mesenchymal Transition and Extracellular Matrix in Rat Alveolar Epithelial Cells and Pulmonary Fibroblasts.
Guo R; Lv Y; Ouyang Y; Liu S; Li D
J Cell Biochem; 2017 Oct; 118(10):3401-3408. PubMed ID: 28322466
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non‑coding RNA DLEU2 suppresses idiopathic pulmonary fibrosis by regulating the microRNA‑369‑3p/TRIM2 axis.
Yi H; Luo D; Xiao Y; Jiang D
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760118
[TBL] [Abstract][Full Text] [Related]
19. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
20. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
Tan QY; Cheng ZS
Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
